The 7 bullish analyst ratings indicate a positive outlook for Mirum Pharmaceuticals. The average price target of $67 suggests a significant upside potential from the current price of $26.7517. This information is important for investors as it shows that analysts have a positive view on the stock, which could lead to an increase in its price in the short term.